Peter U. Park

Peter U. Park

Nessuna posizione attualmente

Health Technology
Finance

Profilo

Dr. Peter U.
Park is Vice President-Biology at Mersana Therapeutics, Inc. Dr. Park was previously employed as Chief Executive Officer by Habgen, Inc. and Senior Director-Discovery Research by ImmunoGen, Inc. He received his undergraduate degree from the Massachusetts Institute of Technology and a doctorate degree from the Massachusetts Institute of Technology.

Precedenti posizioni note di Peter U. Park

SocietàPosizioneFine
IMMUNOGEN, INC. Corporate Officer/Principal -
Habgen, Inc. Amministratore Delegato -
MERSANA THERAPEUTICS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Peter U. Park

Formazione di Peter U. Park

Massachusetts Institute of Technology Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Peter U. Park

Società collegate

Società quotate in Borsa1
MERSANA THERAPEUTICS, INC.

Health Technology

Aziende private2
ImmunoGen, Inc.
Logo ImmunoGen, Inc.

ImmunoGen, Inc.

BiotechnologyHealth Technology

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.

Health Technology

Habgen, Inc.

  1. Borsa valori
  2. Insiders
  3. Peter U. Park